Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.
Katherine A HrebinkoCindy L BryceStephanie M Downs-CannerEmilia J DiegoSara P MyersPublished in: Cancer (2022)
Routine SLNB in this population is not cost-effective. The cost-effectiveness of SLNB, however, is dependent on individual patient factors, including functional status as well as patient preference.